The kidney and cardiovascular outcome trials

被引：42

作者：

Bloomgarden, Zachary ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

JOURNAL OF DIABETES | 2018年 / 10卷 / 02期

关键词：

TIMI; 53; TRIAL; DIABETES-MELLITUS; TYPE-2; EMPAGLIFLOZIN; SAXAGLIPTIN; DISEASE;

D O I：

10.1111/1753-0407.12616

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：88 / 89

页数：2

共 20 条

[1] Sodium-glucose cotransporter 2 inhibitors and renal function [J].

Bloomgarden, Zachary .

JOURNAL OF DIABETES, 2015, 7 (03) :295-298

[2] EVIDENCE FOR A SPLANCHNIC SODIUM INPUT MONITOR REGULATING RENAL SODIUM EXCRETION IN MAN - LACK OF DEPENDENCE UPON ALDOSTERONE [J].

CAREY, RM .

CIRCULATION RESEARCH, 1978, 43 (01) :19-23

[3] Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial [J].

Cherney, David Z. I. ;

Zinman, Bernard ;

Inzucchi, Silvio E. ;

Koitka-Weber, Audrey ;

Mattheus, Michaela ;

von Eynatten, Maximilian ;

Wanner, Christoph .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08) :610-621

[4] Can we go beyond surrogates? [J].

Drexler, Andrew .

JOURNAL OF DIABETES, 2017, 9 (11) :976-977

[5] Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications [J].

Heerspink, Hiddo J. L. ;

Perkins, Bruce A. ;

Fitchett, David H. ;

Husain, Mansoor ;

Cherney, David Z. I. .

CIRCULATION, 2016, 134 (10) :752-772

[6] Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [J].

Ismail-Beigi, Faramarz ;

Craven, Timothy ;

Banerji, Mary Ann ;

Basile, Jan ;

Calles, Jorge ;

Cohen, Robert M. ;

Cuddihy, Robert ;

Cushman, William C. ;

Genuth, Saul ;

Grimm, Richard H., Jr. ;

Hamilton, Bruce P. ;

Hoogwerf, Byron ;

Karl, Diane ;

Katz, Lois ;

Krikorian, Armand ;

O'Connor, Patrick ;

Pop-Busui, Rodica ;

Schubart, Ulrich ;

Simmons, Debra ;

Taylor, Harris ;

Thomas, Abraham ;

Weiss, Daniel ;

Hramiak, Irene .

LANCET, 2010, 376 (9739) :419-430

[7] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [J].

Marso, Steven P. ;

Daniels, Gilbert H. ;

Brown-Frandsen, Kirstine ;

Kristensen, Peter ;

Mann, Johannes F. E. ;

Nauck, Michael A. ;

Nissen, Steven E. ;

Pocock, Stuart ;

Poulter, Neil R. ;

Ravn, Lasse S. ;

Steinberg, William M. ;

Stockner, Mette ;

Zinman, Bernard ;

Bergenstal, Richard M. ;

Buse, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) :311-322

[8] Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus [J].

Mori, Hiroko ;

Okada, Yosuke ;

Arao, Tadashi ;

Tanaka, Yoshiya .

JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) :313-319

[9] Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial [J].

Mosenzon, Ofri ;

Leibowitz, Gil ;

Bhatt, Deepak L. ;

Cahn, Avivit ;

Hirshberg, Boaz ;

Wei, Cheryl ;

Im, KyungAh ;

Rozenberg, Aliza ;

Yanuv, Ilan ;

Stahre, Christina ;

Ray, Kausik K. ;

Iqbal, Nayyar ;

Braunwald, Eugene ;

Scirica, Benjamin M. ;

Raz, Itamar .

DIABETES CARE, 2017, 40 (01) :69-76

[10] GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes [J].

Muskiet, Marcel H. A. ;

Tonneijck, Lennart ;

Smits, Mark M. ;

van Baar, Michael J. B. ;

Kramer, Mark H. H. ;

Hoorn, Ewout J. ;

Joles, Jaap A. ;

van Raalte, Daniel H. .

NATURE REVIEWS NEPHROLOGY, 2017, 13 (10) :605-628

← 1 2 →